The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Immunopathology of multiple sclerosis
Abstract
Two decades of clinical experience with immunomodulatory treatments for multiple sclerosis point to distinct immunological pathways that drive disease relapses and progression. In light of this, we discuss our current understanding of multiple sclerosis immunopathology, evaluate long-standing hypotheses regarding the role of the immune system in the disease and delineate key questions that are still unanswered. Recent and anticipated advances in the field of immunology, and the increasing recognition of inflammation as an important component of neurodegeneration, are shaping our conceptualization of disease pathophysiology, and we explore the potential implications for improved healthcare provision to patients in the future.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The extensive infiltration and activation of peripheral and resident immune cells in MS suggests these cells are key mediators of lesion formation [77, 210, 278] (Fig. 1j-l).”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [77]
In the citing paper
“In addition to possible antigen-specific T cell-mediated inflammation, non-specific inflammation also contributes to myelin destruction in MS [77].”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [77]
In the citing paper
“Since currently available drugs insufficiently mitigate progression of neurodegeneration independent of the MS subtype (2), there is an urgent unmet clinical need for neuroprotective interventions.”
From MicroRNA-92a–CPEB3 axis protects neurons against inflammatory neurodegeneration (2023) · cites this paper as [2]
In the citing paper
“Both conditions have been characterised by immunological abnormalities and dysfunctional myelination, at least in a subset of individuals [170,171].”
From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [171]
In the citing paper
“Furthermore, work from the past few years demonstrates that microglial gene expression changes during aging and may contribute to risk for AD (3) as well as autoimmune disorders of the central nervous system (CNS) such as multiple sclerosis [MS; reviewed in (4)] and lupus (5), but precisely how these cells contribute to risk for autoimmune disorders or AD remains unclear.”
From The Transcriptional Landscape of Microglial Genes in Aging and Neurodegenerative Disease (2019) · cites this paper as [4]
Citations
Cites
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Integrative analysis of 111 reference human epigenomes
Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. (2015) · Nature · doi:10.1038/nature14248 · Cited by 6,368
Compston, A., & Coles, A. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,699
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M., Ferguson, P., Whitesell, L., Kelly, T., Saulsbury, F., Chance, P., & Ochs, H. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,576
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
Gomez Perdiguero, E., Klapproth, K., Schulz, C., Busch, K., Azzoni, E., Crozet, L., Garner, H., Trouillet, C., de Bruijn, M. F., Geissmann, F., et al. (2015) · Nature · doi:10.1038/nature13989 · Cited by 2,339
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–1,000 of 1,003
Yan, J., Winterford, C. M., Catts, V. S., Pat, B., Pender, M. P., McCombe, P., & Greer, J. M. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.04.002 · Cited by 19
Boyко, A., & Boyko, O. V. (2018) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s161450 · Cited by 21
Wan, X., Pei, W., Shahzad, K. A., Zhang, L., Song, S., Jin, X., Wang, L., Zhao, C., & Shen, C. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800108 · Cited by 19
Ninou, I., Sevastou, I. G., Magkrioti, C., Kaffe, E., Stamatakis, G. M., Thivaios, S., Panayotou, G., Aoki, J., Kollias, G. A., & Aidinis, V. (2020) · PLoS ONE · doi:10.1371/journal.pone.0226050 · Cited by 19
Isaiah, S., Loots, D. T., Solomons, R., van der Kuip, M., van Furth, A. M., & Mason, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00296 · Cited by 20
Perivascular tissue resident memory T cells as therapeutic target in multiple sclerosis
Smolders, J., Fransen, N. L., Hsiao, C., Hamann, J., & Huitinga, I. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1776609 · Cited by 22
B Cells in Multiple Sclerosis and Virus-Induced Neuroinflammation
Chunder, R., Schropp, V., & Küerten, S. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.591894 · Cited by 20
Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse
McKay, K. A., Bedri, S. K., Manouchehrinia, A., Stawiarz, L., Olsson, T. P., Hillert, J., & Fink, K. (2022) · Annals of Neurology · doi:10.1002/ana.26301 · Cited by 19
MS ‐Driven Metabolic Alterations Are Recapitulated in iPSC ‐Derived Astrocytes
Ghirotto, B., Oliveira, D., Cipelli, M., Basso, P. J., de Lima, J., Breda, C. N. D. S., Ribeiro, H. C., Silva, C. C. C., Sertie, A. L., Oliveira, A. E. R., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26336 · Cited by 20
Time to first treatment and risk of disability pension in relapsing-remitting multiple sclerosis
Wandall‐Holm, M. F., Buron, M. D., Kopp, T. I., Thielen, K., Sellebjerg, F. T., & Magyari, M. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-329058 · Cited by 19
Exploiting Rational Assembly to Map Distinct Roles of Regulatory Cues during Autoimmune Therapy
Oakes, R. S., Tostanoski, L. H., Kapnick, S. M., Froimchuk, E., Black, S. K., Zeng, X., & Jewell, C. M. (2021) · ACS Nano · doi:10.1021/acsnano.0c07440 · Cited by 18
Duarte-Silva, E. P., Araújo, S. M. D. R., de Oliveira, W. H., Lós, D. B., Bonfanti, A. P., Peron, G., Thomaz, L. D. L., Verinaud, L. M. C., & Peixoto, C. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.671511 · Cited by 18
Smith, K. J., Minns, D., McHugh, B. J., Holloway, R. K., O’Connor, R. A., Williams, A., Melrose, L. A., McPherson, R. C., Miron, V. E., Davidson, D. J., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001554 · Cited by 20
Fettig, N. M., Robinson, H. G., Allanach, J. R., Davis, K. M., Simister, R. L., Wang, E. J., Sharon, A. J., Ye, J., Popple, S., Seo, J. H., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111328 · Cited by 19
Humanized zebrafish as a tractable tool for in vivo evaluation of pro-myelinating drugs
Häberlein, F., Mingardo, E., Merten, N., Köhling, N.-K. S., Reinoß, P., Simon, K., Japp, A. S., Nagarajan, B., Schrage, R., Pégurier, C., et al. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.08.007 · Cited by 18
Fan, X., He, Z., Pang, M.-J., Wang, L.-L., Wang, X.-Y., Sun, D.-W., Wang, Z., Wu, D.-L., & Miao, Z. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122105 · Cited by 19
Teschner, V. E., Fleck, A.-K., Walter, C., Schwarze, A.-S., Eschborn, M., Wirth, T., Steinberg, O. V., Schulte‐Mecklenbeck, A., Lu, I., Herrera-Rivero, M., et al. (2023) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864231211077 · Cited by 18
Martin‐Gutierrez, L., Waddington, K. E., Maggio, A., Coelewij, L., Oppong, A. E., Yang, N., Adriani, M., Nytrová, P., Farrell, R. A., Pineda‐Torra, I., et al. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae032 · Cited by 18
Gao, M., Wang, X., Su, S., Feng, W., Lai, Y., Huang, K., Cao, D., & Wang, Q. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01595 · Cited by 18
Collins, F., Kazmi, M. A., & Muraro, P. A. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1297232 · Cited by 18
Levin, S. N., & Lyons, J. L. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63849-6.00017-7 · Cited by 18
Novakova, L., Singh, A. K., Axelsson, M., Ståhlman, M., Adiels, M., Malmeström, C., Zetterberg, H., Borén, J., Lycke, J., Cardell, S., et al. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14452 · Cited by 18
CD28 between tolerance and autoimmunity: the side effects of animal models
Porciello, N., Kunkl, M., & Tuosto, L. (2018) · F1000Research · doi:10.12688/f1000research.14046.1 · Cited by 18
Huang, K., Lin, M.-N., Hsu, Y., Lu, I.-H., Pan, I.-H., & Yang, J. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/6797030 · Cited by 19
Drohomyrecky, P. C., Doroshenko, E. R., Akkermann, R., Moshkova, M., Yi, T. J., Zhao, F. L., Ahn, J. J., McGaha, T. L., Pahan, K., & Dunn, S. E. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801200 · Cited by 18
Multiple Sclerosis and the Choroid Plexus: Emerging Concepts of Disease Immunopathophysiology
Dixon, G. A., & Pérez, C. A. (2019) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.08.007 · Cited by 19
Effects of interferon and glatiramer acetate on cytokine patterns in multiple sclerosis patients
Ganji, A., Monfared, M. E., Shapoori, S., Nourbakhsh, P., Ghazavi, A., Ghasami, K., & Mosayebi, G. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154911 · Cited by 18
Zhao, Z., Bao, X.-Q., Zhang, Z., Li, F., Liu, H., & Zhang, D. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.03.009 · Cited by 18
Genetic Etiology Shared by Multiple Sclerosis and Ischemic Stroke
Tian, Z., Song, Y., Yao, Y., Guo, J., Gong, Z., & Wang, Z. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00646 · Cited by 18
Recent Advances in Nanomedicines for Multiple Sclerosis Therapy
Zeng, Y., Li, Z., Zhu, H., Gu, Z., Zhang, H., & Luo, K. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00953 · Cited by 18
Bakhuraysah, M. M., Theotokis, P., Lee, J. Y., Alrehaili, A. A., Aui, P.-M., Figgett, W. A., Azari, M. F., Abou-Afech, J.-P., Mackay, F., Siatskas, C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82346-6 · Cited by 18
Hrastelj, J., Andrews, R., Loveless, S., Morgan, J., Bishop, S. M., Bray, N. J., Williams, N. M., & Robertson, N. P. (2021) · Brain Communications · doi:10.1093/braincomms/fcab155 · Cited by 20
Aybar, F., Pérez, M. J., Marcora, M. S., Samman, M. E., Marrodán, M., Pasquini, J. M., & Correale, J. D. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108571 · Cited by 18
Tout, I., & Miossec, P. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103098 · Cited by 18
Koto, S., Chihara, N., Akatani, R., Nakano, H., Hara, A., Sekiguchi, K., Matsumoto, R., & Toda, T. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001166 · Cited by 18
Lie, I. A., Kaçar, S., Wesnes, K., Brouwer, I., Kvistad, S. S., Wergeland, S., Holmøy, T., Midgard, R., Bru, A., Edland, A., et al. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-328568 · Cited by 18
What Have Failed, Interrupted, and Withdrawn Antibody Therapies in Multiple Sclerosis Taught Us?
Krämer, J., & Wiendl, H. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01246-3 · Cited by 18
Murine Cytomegalovirus Infection Induces Susceptibility to EAE in Resistant BALB/c Mice
Milovanović, J., Popović, B., Milovanović, M., Kveštak, D., Arsenijević, A., Stojanović, B., Tanasković, I., Krmpotić, A., Arsenijević, N., Jonjić, S., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00192 · Cited by 18
Chedrawe, M. A. J., Holman, S. P., Lamport, A.-C., Akay, T., & Robertson, G. S. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.06.001 · Cited by 20
Regulation of lymphocyte trafficking in central nervous system autoimmunity
Oukka, M., & Bettelli, E. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.09.008 · Cited by 19
Bo, M., Arru, G., Niegowska, M., Erre, G. L., Manchia, P., & Sechi, L. A. (2019) · Microorganisms · doi:10.3390/microorganisms7100423 · Cited by 18
Molecular Interventions towards Multiple Sclerosis Treatment
Metaxakis, A., Petratou, D., & Tavernarakis, N. (2020) · Brain Sciences · doi:10.3390/brainsci10050299 · Cited by 18
Naffaa, M. M. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.100676 · Cited by 20
Notch3 destabilizes regulatory T cells to drive autoimmune neuroinflammation in multiple sclerosis
Benamar, M., Contini, P., Schmitz‐Abe, K., Lanzetta, O., Getachew, F., Bachelin, C., Leyva-Castillo, J. M., Wang, M., Öktelik, F. B., Perrot, O., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.09.007 · Cited by 17
The Link Among Neurological Diseases: Extracellular Vesicles as a Possible Brain Injury Footprint
Ciccocioppo, F., Lanuti, P., Centonze, D., Miscia, S., & Marchisio, M. (2019) · Neurosignals · doi:10.33594/000000116 · Cited by 17
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis
Gilio, L., Fresegna, D., Gentile, A., Guadalupi, L., Sanna, K., Vito, F. D., Balletta, S., Caioli, S., Rizzo, F. R., Musella, A., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105817 · Cited by 17
Tissue‐Targeted Drug Delivery Strategies to Promote Antigen‐Specific Immune Tolerance
Rui, Y., Eppler, H. B., Yanes, A. A., & Jewell, C. M. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202238 · Cited by 17
Li, H., Zeng, Y., Luo, S., Li, Z., Huang, F., & Liu, Z. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.12.034 · Cited by 17
Beura, S. K., Panigrahi, A. R., Yadav, P., Palacio, I., Casero, E., Quintana, C., Singh, J., Singh, S. K., Martín-Gago, J. Á., & Singh, S. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102205 · Cited by 17
Guadalupi, L., Vanni, V., Balletta, S., Caioli, S., Vito, F. D., Fresegna, D., Sanna, K., Nencini, M., Donninelli, G., Volpe, E., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03120-9 · Cited by 18
Glial cell crosstalk in Parkinson's disease: Mechanisms, implications, and therapeutic strategies
Wang, N., Xiao, X., Chen, Z., Xu, K., Cao, X., Kou, D., & Zeng, J. (2025) · Fundamental Research · doi:10.1016/j.fmre.2024.12.023 · Cited by 18
Roch, L., Hecker, M., Friess, J., Angerer, I. C., Koczan, D., Fitzner, B., Schröder, I., Flechtner, K., Thiesen, H., Meister, S., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0075-0 · Cited by 17
Durose, W. W., Shimizu, T., Li, J., Abe, M., Sakimura, K., Chetsawang, B., Tanaka, K. F., Suzumura, A., Tohyama, K., & Ikenaka, K. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14581 · Cited by 17
Exploring the relationship between Endothelin-1 and peripheral inflammation in multiple sclerosis
Rocha, N. P., Colpo, G. D., Bravo-Alegria, J. B., Lincoln, J. A., Wolinsky, J. S., Lindsey, J. W., Teixeira, A. L., & Freeman, L. A. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.11.007 · Cited by 17
Horebeek, L. V., Hilven, K., Mallants, K., van Nieuwenhuijze, A. E. M., Kelkka, T., Savola, P., Mustjoki, S. M., Schlenner, S., Liston, A., Dubois, B., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy425 · Cited by 17
Clinical trials in multiple sclerosis: potential future trial designs
Manouchehri, N., Zhang, Y., Salter, A. R., Hussain, R. Z., Hartung, H.-P., Hemmer, B., Linker, R. A., Segal, B. M., Cutter, G., & Stüve, O. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419847095 · Cited by 17
Gavriilaki, M., Sakellari, I., Gavriilaki, E., Kimiskidis, V. Κ., & Anagnostopoulos, Α. (2019) · Stem Cells International · doi:10.1155/2019/5840286 · Cited by 19
Multiple Sclerosis: Epidemiology, Genetics, Symptoms, and Unmet Needs
Moreno‐Torres, I., Muñoz, J. S., & García‐Merino, A. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016070-00001 · Cited by 18
Chong, L., Tian, R., Shi, R., Ouyang, Z., & Xia, Y. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00807 · Cited by 17
Amelioration of experimental autoimmune encephalomyelitis by Rhodiola rosea, a natural adaptogen
Lin, X., Liu, Y., Ma, L., Ma, X., Chen, Z., Chen, H. H., Si, L., Ma, X., Yu, Z., & Chen, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109960 · Cited by 17
Dense module searching for gene networks associated with multiple sclerosis
Manuel, A. M., Dai, Y., Freeman, L. A., Jia, P., & Zhao, Z. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-0674-5 · Cited by 17
Bhat, A., Dalvi, H., Jain, H., Rangaraj, N., Singh, S. B., & Srivastava, S. (2020) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2020.100012 · Cited by 17
Prinz, C., Starke, L., Millward, J. M., Fillmer, A., Delgado, P. R., Waiczies, H., Pohlmann, A., Rothe, M., Nazaré, M., Paul, F., et al. (2021) · Theranostics · doi:10.7150/thno.47130 · Cited by 18
Park, J., Choi, S. W., Cha, B. G., Kim, J., & Kang, S. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00946 · Cited by 17
Malla, B., Liotta, A., Bros, H., Ulshöfer, R., Paul, F., Hauser, A. E., Niesner, R. A., & Infante‐Duarte, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031538 · Cited by 18
Targeting IFN-λ Signaling Promotes Recovery from Central Nervous System Autoimmunity
Manivasagam, S., Williams, J. L., Vollmer, L. L., Bollman, B., Bartleson, J. M., Ai, S., Wu, G. F., & Klein, R. S. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2101041 · Cited by 16
Sepasi, T., Ghadiri, T., Kalan, A. E., Bani, F., Talebi, M., Rahbarghazi, R., Khodakarimi, S., Beyrampour-Basmenj, H., Seidi, K., Abbaspour‐Ravasjani, S., et al. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122815 · Cited by 17
The sequence of regional structural disconnectivity due to multiple sclerosis lesions
Tozlu, C., Olafson, E. R., Jamison, K. W., Demmon, E., Kaunzner, U. W., Marcille, M., Zinger, N., Michaelson, N. M., Safi, N., Nguyen, T. D., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad332 · Cited by 17
Cucurbitacin E Potently Modulates the Activity of Encephalitogenic Cells
Jevtić, B., Djedović, N., Stanisavljević, S., Despotović, J., Miljković, D. M., & Timotijević, G. S. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b00951 · Cited by 17
Jayaraman, A. K., Sharma, M., Prabhakar, B. S., Holterman, M., & Jayaraman, S. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.02.008 · Cited by 17
Maple, P. A. C. (2020) · Vaccines · doi:10.3390/vaccines8010035 · Cited by 17
Yetkin, M. F., & Mirza, M. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577307 · Cited by 17
Attenuation of inflammatory response in the EAE model by PEGlated nanoliposome of pistachio oils
Jebali, A., Karimabad, M. N., Ahmadi, Z., Khorramdel, H., Kaeidi, A., Mirzaei, M., Zare‐Bidaki, M., Ahmadinia, H., Vakilian, A., Darekordi, A., et al. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577352 · Cited by 17
Mooshekhian, A., Sandini, T. M., Wei, Z., van Bruggen, R., Li, H., Li, X., & Zhang, Y. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11133 · Cited by 16
Zhou, Q., Jia, R., & Dang, J. (2022) · Neurology Research International · doi:10.1155/2022/3265029 · Cited by 17
Tonev, D. G., & Momchilova, A. (2023) · Biomedicines · doi:10.3390/biomedicines11020328 · Cited by 16
Role of Artesunate in Autoimmune Diseases and Signaling Pathways
Gu, J., Xu, Y., Hua, D., & Chen, Z. (2023) · Immunotherapy · doi:10.2217/imt-2023-0052 · Cited by 16
The therapeutic potential of exosomes in immunotherapy
Li, G., Zhang, S., Zou, Y., Ai, H., Zheng, X., Qian, K., Lei, C., & Fu, W. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1424081 · Cited by 16
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective
Sabatino, E. D., Ferraro, D., Gaetani, L., Emiliano, E., Parnetti, L., & Filippo, M. D. (2025) · Journal of Neurology · doi:10.1007/s00415-025-12907-6 · Cited by 17
Guo, R., Zhao, Y., Li, J., Gu, Y., Huo, H.-X., Li, S., Song, Y., Zhu, Z., & Tu, P. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00281 · Cited by 16
Araman, C., van Gent, M. E., Meeuwenoord, N. J., Heijmans, N., Marqvorsen, M. H. S., Doelman, W., Faber, B. W., Hart, B. A. ‘., & van Kasteren, S. I. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00852 · Cited by 16
Weng, Q., Che, J., Zhang, Z., Zheng, J., Zhan, W., Lin, S., Tian, T., Wang, J., Gai, R., Hu, Y., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01635 · Cited by 16
microRNAs: key modulators of disease-modifying therapies in multiple sclerosis
Ehtesham, N., Mosallaei, M., Karimzadeh, M. R., Kazerouni, H. M., & Sharifi, M. (2020) · International Reviews of Immunology · doi:10.1080/08830185.2020.1779712 · Cited by 16
Disturbed Presynaptic Ca2+ Signaling in Photoreceptors in the EAE Mouse Model of Multiple Sclerosis
Mukherjee, A., Katiyar, R., Dembla, E., Dembla, M., Kumar, P., Belkacemi, A., Jung, M., Beck, A., Flockerzi, V., Schwarz, K., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101830 · Cited by 16
Deftereos, S., & Georgonikou, D. D. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.12.001 · Cited by 16
Dynamic glial response and crosstalk in demyelination-remyelination and neurodegeneration processes
Shields, C. B., Cai, J., Chu, T., Shields, L. B. E., Zeng, W., Zhang, Y., Wang, Y., & Barnes, G. N. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.300975 · Cited by 21
Swartz, A. M., Congdon, K. L., Nair, S. K., Li, Q.-J., Herndon, J. E., Suryadevara, C. M., Riccione, K. A., Archer, G. E., Norberg, P. K., Sanchez-Perez, L. A., et al. (2021) · npj Vaccines · doi:10.1038/s41541-020-00273-5 · Cited by 16
Martínez‐Pinilla, E., Rubio-Sardón, N., Peláez, R., García-Álvarez, E., del Valle, E., Tolivia, J., Larráyoz, I. M., & Navarro, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031260 · Cited by 16
Diagnosis of multiple sclerosis using multifocal ERG data feature fusion
López-Dorado, A., Perez, J. L., Rodrigo, M. J., Miguel, J. M., Ortiz, M., de Santiago, L., López-Guillén, E., Blanco, R., Cavalliere, C., Sánchez‐Morla, E. M., et al. (2021) · Information Fusion · doi:10.1016/j.inffus.2021.05.006 · Cited by 17
An Overview of Peptide-Based Molecules as Potential Drug Candidates for Multiple Sclerosis
Gatto, A. D., Saviano, M., & Zaccaro, L. (2021) · Molecules · doi:10.3390/molecules26175227 · Cited by 16
Assessment of cognitive functions in patients with multiple sclerosis
Al-Falaki, T. A., Hamdan, F. B., & Sheaheed, N. M. (2021) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-021-00383-4 · Cited by 17
Kesharwani, A., Schwarz, K., Dembla, E., Dembla, M., & Schmitz, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910789 · Cited by 16
Mancini, V. S. B. W., Pietro, A. A. D., de Olmos, S., Pinto, P. S., Vence, M., Marder, M., Igaz, L. M., Marcora, M. S., Pasquini, J. M., Correale, J. D., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15566 · Cited by 16
Guo, G., Zhang, H., Yao, L., Li, H., Xu, C., Li, Z., & Xu, W. (2021) · Proceedings of the ACM on Interactive Mobile Wearable and Ubiquitous Technologies · doi:10.1145/3494970 · Cited by 17
Tremolanti, C., Cavallini, C., Meyer, L., Klein, C., Pozzo, E. D., Costa, B., Germelli, L., Taliani, S., Patte‐Mensah, C., & Mensah‐Nyagan, A. G. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02737-2 · Cited by 17
Circulating long noncoding RNAs as novel bio-tools: Focus on autoimmune diseases
Karimi, B., Firoozabadi, A. D., Peymani, M., & Ghaedi, K. (2022) · Human Immunology · doi:10.1016/j.humimm.2022.06.001 · Cited by 17
Oral Pathobionts Promote MS-like Symptoms in Mice
Zhou, L., Lin, W.-Z., Liu, T., Chen, B.-Y., Meng, X.-Q., Li, Y., Du, L., Liu, Y., Qian, Y.-C., Zhu, Y., et al. (2022) · Journal of Dental Research · doi:10.1177/00220345221128202 · Cited by 16
Palermo, F., Pieroni, N., Sanna, A., Parodi, B., Venturi, C. B., Provinciali, G. B., Massimi, L., Maugeri, L., Marra, G. P., Longo, E., et al. (2022) · Communications Physics · doi:10.1038/s42005-022-01070-3 · Cited by 16
Parsons, M. E. M., O’Connell, K., Allen, S., Egan, K., Szklanna, P. B., McGuigan, C., Áinle, F. N., & Maguire, P. B. (2017) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217317747624 · Cited by 16
Allanach, J. R., Fettig, N. M., Hardman, B. K., Rosen, A. R., Fan, V., Chung, C., Goldberg, E. J., Morse, Z. J., Shanina, I., Vorobeychik, G., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu5110 · Cited by 14
Metadata
- Authors
- Dendrou, C. A., Fugger, L., & Friese, M. A.
- Affiliations
- John Radcliffe Hospital (GB)
- Aarhus University Hospital (DK)
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- Fugger, Lars
- Venue
- Nature Reviews Immunology
- Published
- 2015-08-07
- Volume
- 15
- Issue
- 9
- Pages
- 545-558
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1828576284
- Cited by
- 2,215
- References
- 122
- Citations by year
- 2026: 117 · 2025: 177 · 2024: 243 · 2023: 230 · 2022: 252 · 2021: 272 · 2020: 257 · 2019: 216 · 2018: 201 · 2017: 159 · 2016: 83 · 2015: 5
- FWCI
- 21.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (100308/Z/12/Z, 100308)
- Alan and Babette Sainsbury Charitable Fund
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- multiple sclerosis, immunopathology, genetic susceptibility, environmental triggers, neuroinflammation, neurodegeneration, immunomodulatory therapy, recurrence, disease progression
- MeSH terms
- Environmental Exposure, Humans, Inflammation, Multiple Sclerosis, Autoimmunity, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review